Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 7
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Setién-Suero, Esther Suárez-Pinilla, Marta Suárez-Pinilla, Paula Crespo-Facorro, Benedicto and Ayesa-Arriola, Rosa 2016. Homocysteine and cognition: A systematic review of 111 studies. Neuroscience & Biobehavioral Reviews, Vol. 69, p. 280.

    Harris, Elizabeth Macpherson, Helen and Pipingas, Andrew 2015. Improved Blood Biomarkers but No Cognitive Effects from 16 Weeks of Multivitamin Supplementation in Healthy Older Adults. Nutrients, Vol. 7, Issue. 5, p. 3796.

    Raszewski, Grzegorz Loroch, Małgorzata Owoc, Alfred Łukawski, Krzysztof Filip, Rafał and Bojar, Iwona 2015. Homocysteine and cognitive disorders of postmenopausal women measured by a battery of computer tests—central nervous system vital signs. Archives of Women's Mental Health, Vol. 18, Issue. 4, p. 623.

    Abais, Justine M. Xia, Min Li, Guangbi Gehr, Todd W.B. Boini, Krishna M. and Li, Pin-Lan 2014. Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia. Free Radical Biology and Medicine, Vol. 67, p. 211.

    Moustafa, Ahmed A. Hewedi, Doaa H. Eissa, Abeer M. Frydecka, Dorota and Misiak, Błażej 2014. Homocysteine levels in schizophrenia and affective disorders—focus on cognition. Frontiers in Behavioral Neuroscience, Vol. 8,

    Jochemsen, Hadassa M. Kloppenborg, Raoul P. de Groot, Lisette C.P.G.M. Kampman, Ellen Mali, Willem P.T.M. van der Graaf, Yolanda and Geerlings, Mirjam I. 2013. Homocysteine, progression of ventricular enlargement, and cognitive decline: The Second Manifestations of ARTerial disease-Magnetic Resonance study. Alzheimer's & Dementia, Vol. 9, Issue. 3, p. 302.

    Nachum-Biala, Yaarit and Troen, Aron M. 2012. B-vitamins for neuroprotection: Narrowing the evidence gap. BioFactors, Vol. 38, Issue. 2, p. 145.


Plasma homocysteine and cognitive decline in older hypertensive subjects

  • Sunil K. Narayan (a1), Brian K. Saxby (a1), Michael J. Firbank (a1), John T. O'Brien (a1), Frances Harrington (a1), Ian G. McKeith (a1), Monica Hansrani (a2), Gerard Stansby (a3) and Gary A. Ford (a1)
  • DOI:
  • Published online: 06 May 2011

Background: Elevated plasma homocysteine concentrations have been associated with both cognitive impairment and dementia. However, it is unclear whether some cognitive domains are more affected than others, or if this relationship is independent of B12 and folate levels, which can also affect cognition. We examined the relationship between plasma homocysteine and cognitive decline in an older hypertensive population.

Methods: 182 older people (mean age 80 years) with hypertension and without dementia, were studied at one center participating in the Study on COgnition and Prognosis in the Elderly (SCOPE). Annual cognitive assessments were performed using a computerized assessment battery and executive function tests, over a 3–5 year period (mean 44 months). Individual rates of decline on five cognitive domains were calculated for each patient. End of study plasma homocysteine, folate and B12 concentrations were measured. The relationship between homocysteine levels and cognitive decline was studied using multivariate regression models, and by comparing high versus low homocysteine quartile groups.

Results: Higher homocysteine showed an independent association with greater cognitive decline in three domains: speed of cognition (β = −27.33, p = 0.001), episodic memory (β = −1.25, p = 0.02) and executive function (β = −0.05, p = 0.04). The association with executive function was no longer significant after inclusion of folate in the regression model (β = −0.032, p = 0.22). Change in working memory and attention were not associated with plasma homocysteine, folate or B12. High homocysteine was associated with greater decline with a Cohen's d effect size of approximately 0.7 compared to low homocysteine.

Conclusions: In a population of older hypertensive patients, higher plasma homocysteine was associated with cognitive decline.

Corresponding author
Correspondence should be addressed to: Professor Gary A. Ford, Level 6 Leazes Wing, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK. Phone: +44–191-222-7744; Fax: +44-191-282-0288. Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

M. M. Budge , C. A. De Jager , E. Hogervorst , A. D. Smith and Oxford Project to Investigate Memory and Ageing (Optima) (2002). Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. Journal of the American Geriatrics Society, 50, 20142018.

R. Clarke , A. D. Smith , K. A. Jobst , H. Refsum , L. Sutton and P. M. Ueland (1998). Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Archives of Neurology, 55, 14491455.

J. Durga (2007). Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet, 369, 208216.

M. F. Elias (2005). Homocysteine and cognitive performance in the Framingham Offspring Study: age is important. American Journal of Epidemiology, 162, 644653.

L. Feng , T. P. Ng , L. Chuah , M. Niti and E. H. Kua (2006). Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: findings from the Singapore Longitudinal Ageing Study. American Journal of Clinical Nutrition, 84, 15061512.

M. Folstein , S. Folstein and P. McHugh (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinican. Journal of Psychiatric Research, 12, 189198.

A. H. Ford (2010). Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology, 75, 15401547.

A. Garcia , Y. Haron , K. Pulman , L. Hua and M. Freedman (2004). Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study. Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 59, 13231327.

L. Hansson (1999). Study on COgnition and Prognosis in the Elderly (SCOPE). Blood Pressure, 8, 177183.

Homocysteine Studies Collaboration (2002). Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA, 288, 20152022.

B. Hooshmand (2010). Homocysteine and holotranscobalamin and the risk of Alzheimer Disease: a longitudinal study. Neurology, 75, 14081414.

D. M. Kado (2005). Homocysteine versus the vitamins folate, B6 and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Amercian Journal of Medicine, 118, 161167.

S. Kalmijn , L. J. Launer , J. Lindemans , M. L. Bots , A. Hofman and M. M. Breteler (1999). Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. The American Journal of Epidemiology, 150, 283289.

S. Lonati (2004). Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer. Clinical Chemistry and Laboratory Medicine, 42, 228234.

A. McCaddon and B. Regland (2006). Homocysteine and cognition: no longer a hypothesis? Medical Hypotheses, 66, 682683.

P. Muda (2005). Effect of antihypertensive treatment with candesartan or amlodipine on glutathione and its redox status, homocysteine and vitamin concentrations in patients with essential hypertension. Journal of Hypertension, 23, 105112.

H. E. Nelson and A. O'Connell (1978). Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex, 14, 234244.

E. Nurk (2005). Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study. Annals of Neurology, 58, 847857.

ONTARGET Investigators (2008). Telmisartan, ramipril, or both in patients at high risk for vascular events. New England Journal of Medicine, 358, 15471559. doi: 10.1056/NEJMoa0801317.

N. D. Prins (2002). Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology, 59, 13751380.

R. Reitan (1958). Validity of the trailmaking test as an indicator of organic brain damage. Perceptual Motor Skills, 8, 271276.

B. K. Saxby , F. Harrington , I. G. Mckeith , K. A. Wesnes and G. A. Ford (2003). Effects of hypertension on attention, memory, and executive function in older adults. Health Psychology, 22, 587591.

B. K. Saxby , F. Harrington , K. A. Wesnes , I. G. Mckeith and G. A. Ford (2008). Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial. Neurology, 70, 18581866.

J. H. Schafer , T. A. Glass , K. I. Bolla , M. Mintz , A. E. Jedlicka and B. S. Schwartz (2005). Homocysteine and cognitive function in a population-based study of older adults. Journal of the American Geriatrics Society, 53, 381388.

S. Seshadri (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England Journal of Medicine, 346, 476483.

P. Simpson , D. Surmon , K. A. Wesnes and G. Wilcock (1991). The Cognitive Drug Research computerized assessment system for demented patients: a validation study. International Journal of Geriatric Psychiatry, 6, 95102.

A. D. Smith (2010). Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS ONE, 5, e12244. doi: 10.1371/journal.pone.0012244.

O. Spreen and E. Strauss (1997). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York: Oxford University Press.

A. M. Troen (2005). The central nervous system in animal models in hyperhomocysteinemia. Progress in Neuro-Pyschopharmacology and Biological Psychiatry, 29, 11401151.

F. van Dam and W. A. van Gool (2009). Hyperhomocysteinemia and Alzheimer's disease: a systematic review. Archives of Gerontology and Geriatrics, 48, 425430.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *